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Xenopus laevisVertebrate heart development is derived from paired primordia of anterior dorsolateral mesoderm
expressing Nkx2.5 and GATA4 transcription factors. Yet growth factors and intracellular pathways specifying
heart precursor gene expression are poorly understood. In the present work, we investigated the signaling
events initiating Nkx2.5 expression in Xenopus laevis. We describe here that ﬁbroblast growth factor (FGF)
initiates the expression of Nkx2.5 without affecting GATA4. At gastrula, FGF3 is expressed in anterior neural
ectoderm, and results presented here indicate that this tissue is involved in the induction of Nkx2.5
expression in neighboring lateral tissues. Further studies indicate that the intracellular p38 MAPK and the
CREB transcription factor function downstream of FGF to initiate Nkx2.5 expression. Activation of the p38
MAPK pathway and of the CREB protein is both necessary and sufﬁcient for the initial expression of Nkx2.5.
Therefore, we would like to suggest that FGF expressed in anterior neural ectoderm is a major inducer of
Nkx2.5 expression in neighboring cells. In these cells, FGF activates an intracellular p38 MAPK signaling
pathway and its downstream target, the CREB transcription factor, all participating in the expression of
Nkx2.5 in cardiac progenitors.
© 2009 Elsevier Inc. All rights reserved.Introduction
During gastrulation, bilateral symmetrical regions of anterior
mesoderm become speciﬁed to the cardiac lineage. As neurulation
proceeds, the presumptive cardiac mesoderm extends laterally to
eventually fuse at the ventral midline. The signals that specify the
cardiac progenitors originate at the Spemann organizer and its
underlying endoderm. Surgical removal of the endoderm at the
onset of gastrulation prevents heart formation (Cooke, 1989; Sater
and Jacobson, 1989). Since early speciﬁcation occurs dorsally,
patterning signals antagonizing bone morphogenetic proteins
(BMPs) and canonical Wnt pathways secreted by the Spemann
organizer are necessary for the initial competence of heart primordia
(Schneider and Mercola, 2001). Therefore, it is difﬁcult to distinguish
the direct effects of these morphogens on heart formation from
indirect effects mediated by their role in body patterning. In Xenopus,
the deep endoderm underlying the dorsal marginal zone (DMZ)
secrete Cerberus, a BMP,Wnt and Nodal antagonist which is necessary
for the induction of heart (Schneider and Mercola, 1999). Endoderm-
secreted Cerberus and organizer secreted DKK1, a Wnt antagonist
function in parallel to initiate cardiogenesis (Foley et al., 2007).rsal marginal zone; AC, animal
PK, mitogen-activated protein
.
ll rights reserved.Secretion of BMP ligands from endoderm at later stages is essential for
later cardiac development, such as migration and fusion of heart
primordia, cardiomyocyte differentiation (Walters et al., 2001) and
heart looping (Breckenridge et al., 2001; Peterkin et al., 2003). In the
chick, the ability of endoderm to initiate cardiac fate depends on the
activity of BMPs (Schultheiss et al., 1995; Schultheiss et al., 1997) and
of ﬁbroblast growth factor 8 (FGF8) (Alsan and Schultheiss, 2002).
Identifying molecules initiating cardiac speciﬁcation in the frog took
advantage of explant assays. Molecules such as Alk4 (TGFβ) (Logan
and Mohun, 1993) and Wnt11 (non-canonical pathway) (Pandur et
al., 2002) induced cardiogenesis of multipotent animal cap (AC)
explants. The role of FGF signaling in the initiation of cardiac
development in Xenopus was overlooked since early studies of
Amaya and colleagues (1991, 1993) that convincingly demonstrated
that the expression of a dominant-negative mutant form of the FGF
receptor disrupted mesoderm formation altogether.
One of the earliest markers of cardiac fate is the homeobox
transcription factor Nkx2.5, the homologue of Drosophila cardiac
regulator Tinman, which expression is initiated at cardiac speciﬁca-
tion in the gastrula through the subsequent onset of cardiac
differentiation in the tailbud embryo. Transcripts of Nkx2.5 are ﬁrst
detected during late gastrulation (stage 12) as two symmetrical
patches of lateral anterior mesoderm (Tonissen et al., 1994; Sparrow
et al., 2000). Nkx2.5 expression persists during the ventral expansion
of cardiac progenitors and later at the forming heart tube and
morphogenesis of the heart. Expression of Nkx2.5 is not limited to the
cardiac lineage only, since it is expressed in other regions such as
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family members functions as an initial speciﬁcation factor of cardiac
lineage at gastrulae together with other transcription factors of the
GATA family. The signals regulating the expression of Nkx2.5 are only
partially explored. BMP ligands are implicated in the maintenance of
Nkx2.5 expression at the ventral heart ﬁeld region (Shi et al., 2000;
Walters et al., 2001; Peterkin et al., 2003). Yet, the initial signals
inducing Nkx2.5 expression at the anterior-lateral mesoderm in Xe-
nopus are less understood. While we have some knowledge of the
extracellular ligands participating in cardiac Nkx2.5 expression, we
lack knowledge of the intracellular events.
In the present study, we askedwhat are the extra- and intracellular
signals initiating the expression of Nkx2.5. We identiﬁed the
intracellular signaling pathway of p38 MAPK phosphorylating the
CREB transcription factor that together function to initiate the
expression of Nkx2.5 and later cardiac fate. This intracellular pathway
is activated by FGF signaling that is expressed in anterior neural
ectoderm of gastrulating embryos. We present evidence that anterior
neural ectoderm induces the initial expression of Nkx2.5 in neighbor-
ing lateral tissues.Materials and methods
Embryonic manipulation
Ovulation, in vitro fertilization, embryo culture and dissections
were carried out as described (Re'em-Kalma et al., 1995). Embryos
were staged according to (Nieuwkoop and Faber, 1967). Embryos
were taken at different stages and analyzed for immunohistochem-
istry and whole-mount in situ hybridization assays. Ventral marginal
zone (VMZ) and dorsal marginal zone (DMZ, 60° in size) explants
were removed at stages 10–10.25 and cultured to different stages as
described (Bonstein et al., 1998). Animal cap explants were removed
at stages 8–9 and cultured to different stages as described. In some
experiments, explants were treated at different stages with LiCl
(120 mM), bFGF (puriﬁed from bacteria, 150 ng\ml; Henig et al.,
1998), the p38 inhibitor SB 203580 (30 μM), the FGF inhibitor SU 5402
(30 μM) and the ERK MAPK inhibitor U0126 (30 μM).Microinjections
Capped synthetic RNA of activated MKK6 (MKK6E) (0.1 ng),
inactive MKK6 (MKK6A) (0.1 ng), VP16-CREB (0.15 ng), Alk4 (25 pg),
DN FGFR (XFD) (0.05 ng), FGF8 (0.1 ng), DN BMPR (0.05 ng) and two
antisense morpholino oligonucleotides (AMO) were from Gene Tools,
CREB (5′CACTGCCTCCTCTCCGTCACATTGG3′),
Xp38α (5′GACGTAAGATTGATTGGATGACATA3′) were injected
into the marginal zone of one- or two-cell stage embryos in 0.3×
MR containing 3% Ficoll. In some experiments, capped RNA (0.1 ng)
encoding nuc-βgal was injected along with the MKK6E or VP16-CREB
into the marginal zone of two-cell stage embryos later stained with
x-Gal in order to identify the injected side of the embryo.Western blot analysis
Protein extracts were prepared as described (Zetser et al., 2001).
Equal amounts of extracted proteins were loaded (approximately
40 μg), separated by SDS–polyacrylamide gel electrophoresis and
transferred to nitrocellulose ﬁlters by standard methods. Primary
antibodies to CREB, phospho-CREB, ERK, phospho-ERK (Cell Signaling)
andα-tubulin (Sigma) were used. Secondary HRP-conjugated antibody
was detected using the Pierce SuperSignal chemiluminescence detec-
tion system.In situ hybridization (ISH) and immunohistochemistry
ISH was carried out with digoxigenin-labeled probes (Hemmati-
Brivanlou et al., 1990; Harland, 1991; Zetser et al., 2001) Embryos
were cultured to different stages and subsequently ﬁxed for in situ
hybridization. XNkx2.5, XGATA4, Xmhcα and FGF3 speciﬁc probes
were used. Whole-mount immunostaining was performed as de-
scribed (Brivanlou and Harland, 1989). ISH on slides was preformed
as was described before (Butler et al., 2001). For immunohistochem-
istry on sections, slides were deparafﬁnized and hydrated with a
decreased alcohol gradient. Then sections were blocked with goat
serum for 1 h following 12-h incubation with the primary antibody
(Troponin I). Slides were incubated with a secondary rhodamine-
conjugated antibody, counterstained with TO-PRO-3 and were
visualized by confocal microscopy. Alternatively, deparafﬁnized
parafﬁn sections were reacted for 14 h at 4 °C with antibody to
pCREB (1:40). This was followed by incubation with an appropriate
biotinylated secondary antibody, streptavidin–peroxidase conjugate
and S-(2-aminoethyl)-L-cysteine (AEC) as a substrate (Histostain-SP
kit; Zymed Laboratory, San Francisco, CA, USA); counterstaining was
done with hematoxylin. Immunostaining of whole embryos (St.16)
with anti phospho-CREB antibody was performed; prior to antibody
incubation, embryos were incubated with H2O2:methanol (1:10) to
inactivate endogenous peroxidase. Bound antibody was detected with
horseradish–peroxidase (HRP)-conjugated secondary antibody (goat
anti-rabbit IgG;Pierce) diluted 1:100 and was visualized with HRP
staining.
Histological procedure
Slides were deparafﬁnized and hydrated with a decreasing alcohol
concentrations. Then slides were submitted to histological analysis by
optical microscopy. The hematoxylin–eosin method was used to stain
the tissue.
RT-PCR
RT-PCR was performed as described (Wilson and Melton, 1994),
except that random hexamers (100 ng per reaction) were used for
reverse transcription. Primers for XHis4 (Gawantka et al., 1995),
MHCα, MLC2, GATA4, Nkx2.5, Myocardin (Small et al., 2005), FGF3,
FGF4, FGF8, FGFR1, FGFR3 and FGFR4a (Monsoro-Burq et al., 2003)
were described.
Results
Knockdown of p38α prevents the formation of the heart
In previous studies, we analyzed the role of p38 MAPK in the
Spemann organizer (Keren et al., 2008) and in skeletal myogenesis
(Keren et al., 2005). One effect of morpholino-mediated p38α
knockdown noticed in these studies was the absence of beating
hearts in tadpoles. To further investigate this phenomenon, morpho-
lino-injected embryos as well as control uninjected embryos were
transverse sectioned at the heart plane (Fig. 1A). The heart
morphology with its distinct tissues observed in control embryo is
completely lost in the knockdown embryo. Instead, an unorganized
group of cells is apparent. Interestingly, the foregut wall appears
relatively unaffected in the knockdown embryo compared to the
control embryo. Co-injection of transcripts encoding mouse p38
together with p38α AMO partially rescued the heart tubemorphology
(Fig. 1A). Troponin I immunostaining of embryos is indicative of a
complete absence of myocardium in the knockdown embryo (Fig. 1B).
Similarly, a signiﬁcant reduction in the expression of cardiac isoform
of myosin heavy chain (MHCα) by in situ hybridization and semi-
quantitative RT-PCR analyses is observed (Fig. 1C). Together, these
Fig. 1. Knockdown of p38α prevents heart development. (A) Anterior transverse sections of stage 38 control embryos with ventral heart structures, embryos injected with p38α
AMO missing heart structures and embryos injected with p38α AMO and a transcript encoding mouse p38αwith some heart structures. Sections were hematoxylin–eosin stained.
(B) Anterior transverse sections of stage 46 control embryos or of embryos injected with p38α AMO. Sections were immunostained with antibodies to Troponin I (red) and
counterstained with TO-PRO-3 (nuclear, blue). (C) Left panel: In situ hybridization staining of stage 30 embryos with a probe detecting myosin heavy chain α. At the two-cell stage,
one blastomer was injected with p38α AMO (n=38). Control group (n=34) was not injected. Right panel: Embryos were injected with p38α AMO, DMZ explants (n=18) were
isolated and grown to stage 30. Total RNA was isolated and RT-PCR analysis was performed.
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important to note that the effect of p38-knockdown was not speciﬁc
only to the heart formation, since we could detect mild defects in the
anterior structures of the eyes and brain (not shown). This is not
surprising since p38MAPK affects also embryo patterning at an earlier
developmental stage (Keren et al., 2008). We relate to the speciﬁcity
of p38 hereafter (see Supplementary Fig. 4).
The expression of Nkx2.5 is affected by the p38 MAPK pathway
Two families of transcription factors, GATA and Nkx, are among the
ﬁrst to be expressed in heart progenitors and function at different
stages of heart development (reviewed in Latif et al., 2006). Next, we
analyzed how the p38 pathway affected the expression of two
prototypic members of these families, GATA4 and Nkx2.5 (Fig. 2).
Similar results to those presented below were obtained with other
members, GATA5 and Nkx2.3 (not shown). Injection of p38α
morpholino into one of two blastomere embryos abolished the
expression of Nkx2.5 without affecting GATA4 expression at the
injected side of stage 13 embryos (Fig. 2A, upper panel). At this stage,Nkx2.5 and GATA4 are co-expressed as bilateral anterior patches. At
later tailbud stage, knockdown of p38α prevented Nkx2.5 but did not
affect GATA4 expression at the ventral heart ﬁeld (Fig. 2A, lower
panel). The effect of p38α knockdown on the expression of GATA4 and
Nkx2.5 was further studied in several explant assays (Fig. 2B). In one,
DMZ explants of native cardiac progenitors were isolated at stage
10.25 (Sater and Jacobson, 1990). In another, pluripotent animal cap
explants from Alk4 (Activin type I receptor )-injected embryos were
isolated at stage 8 (Logan and Mohun, 1993). Activin signaling
induces different mesodermal fates including cardiac gene expression
in isolated animal caps (Ariizumi et al., 1991; Gurdon et al., 1994). In
another, VMZ explants were isolated at 10.25 from LiCl-treated
embryos (Slack et al., 1988). In all cases, injection of p38αmorpholino
reduced Nkx2.5 expression without affecting the expression of GATA4
(Fig. 2B). The speciﬁcity of p38αmorpholino was investigated by the
co-injection transcripts encoding a non-targetable mouse p38α
(Supplementary Fig. 1). Expression of mouse p38α rescued the
expression of Nkx2.5 in p38αmorpholino-treated embryos. A second
approach was used to reduce p38 activity. An inactive mutant of
MKK6 (MKK6A) was injected to embryos. Its expression signiﬁcantly
Fig. 2. The p38 MAPK pathway is involved in the early expression of Nkx2.5. (A) One of two blastomeres (upper panel) or two of two blastomeres (lower panel) were injected with
p38α AMO, and the expression of Nkx2.5 and GATA4was detected by in situ hybridization of stage 13 (top) and stage 33 (bottom) embryos. (B) p38α AMOwas injected to embryos,
and gene expression was assessed in three cardiac explant assays; DMZ explants (left), AC explants from Alk4-expressing embryos (middle) and VMZ explants from LiCl-treated
embryos (right). At stage 15, total RNA was isolated and RT-PCR analysis was performed. (C) Transcripts encoding inactive MKK6 (MKK6A) were injected to one cell embryos, and
DMZ explants (n=18) were isolated and were grown to stage 15. Total RNA was isolated and RT-PCR analysis was performed. (D) Upper panel: Transcripts encoding MKK6E were
injected to one of two blastomere embryos (n=24). Embryos were allowed to develop to stage 14 and in situ hybridization was performed with a probe to Nkx2.5. The injected side
was recognized by the staining of a β-Gal lineage tracer. Lower panel: Transcripts encoding MKK6Ewere injected to one cell embryos, VMZ explants (n=18) were isolated andwere
grown to stage 14. Total RNA was isolated and RT-PCR analysis was performed.
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loss of p38 expression or activity reduces Nkx2.5 expression.
To induce p38 activity, transcripts encoding constitutive active
mutant of MKK6 (MKK6E) were injected to embryos. In oneexperiment, transcripts were injected to one of two blastomere
embryos and Nkx2.5 expression was analyzed by in situ hybridization
(Fig. 2D, upper panel). Expanded expression domain of Nkx2.5 was
observed in the injected side of embryos relative to the uninjected
side. In another experiment, the expression of Nkx2.5 was induced in
VMZ explants isolated from MKK6E-injected embryos (Fig. 2D, lower
panel). Basal level of GATA4 expression in VMZ explants was not
further induced by ectopic MKK6E. Together, these results indicate
that the p38 MAPK pathway affect the early expression of Nkx2.5
without affecting the expression of GATA4.
The CREB transcription factor functions downstream of p38 MAPK and
affects cardiac expression
In our previous study, CREB was identiﬁed as a target of p38 MAPK
at the Spemann organizer (Keren et al., 2008). Phosphorylation of
CREB at serine 133 may therefore serve as an indicator for the activity
of p38 MAPK. Next, we analyzed the role of CREB in cardiac gene
expression. First, CREB phosphorylation at serine 133 was analyzed by
immunostaining of stage 16 embryos (Fig. 3A). Phospho-CREB is
detectedby a typical spotted-nuclear staining. Itwas scattered inmany
regions of embryos, mostly in the epidermis (A.K. unpublished
results), but its staining was intensiﬁed in a furrow-like structure at
the anterior ventral part of the embryo. In situ staining of stage 16
embryos detected similar pattern of Nkx2.5 expression (Fig. 3A). Thus,
expression of phospho-CREB appears to overlap with the expression of
Nkx2.5 at this particular stage and also at an earlier stage (see Fig. 4A). To
determine possible involvement of CREB in Nkx2.5 expression, CREB
AMO was injected to embryos and several explants assays were used
to assess the expression of cardiac Nkx2.5 (Fig. 3B). In all three explant
assays, knockdown of CREB signiﬁcantly reduced Nkx2.5 expression
while did not affect and even induced the expression of GATA4.
Reduced expression of Nkx2.5 was correlated with later loss of cardiac
gene expression since CREB knockdown inhibited late expression of
cardiac differentiation markers (Fig. 3B, lower panel). Next, we
analyzed whether CREB activity was sufﬁcient to induce Nkx2.5
expression in VMZ explants (Fig. 3C). Transcripts encoding activated
form of CREB (VP16-CREB) were injected to embryos and the
expression of several cardiac genes was analyzed in VMZ explants.
Expression levels of Nkx2.5 and Myocardin were induced while that of
GATA4 was not affected (Fig. 3C, left panel). In a similar experiment,
VP16-CREB was expressed in half embryos and Nkx2.5 was identiﬁed
by in situ hybridization (Fig. 3C, right panel). The expression domain of
Nkx2.5 was expanded in the injected side relative to the uninjected
side of the embryo. These results indicate that CREB is sufﬁcient to
induce Nkx2.5 expression. To determine whether p38 and CREB share
the same pathway, the following experiments were performed (Fig.
3D): In the ﬁrst, ectopic expression of MKK6E induced Nkx2.5 in VMZ
explants. Simultaneous knockdown of CREB prevented Nkx2.5 expres-
sion while augmented GATA4 expression (left panel). In the second,
knockdown of p38α inhibited Nkx2.5 expression in DMZ explants and
simultaneous expression of VP16-CREB rescued the expression ofFig. 3. The CREB protein is involved in the expression of Nkx2.5 downstream of p38
MAPK. (A) Stage 16 embryos were immunostained using an antibody to phospho-CREB
(S133) (left) or analyzed by in situ hybridization with a probe to Nkx2.5 (right). (B)
CREB AMO was injected to embryos, and gene expression was assessed in three cardiac
explant assays; DMZ explants (left), AC explants from Alk4-expressing embryos
(middle) and VMZ explants from LiCl-treated embryos (right). At stage 15 or stage 23,
total RNA was isolated and RT-PCR analysis was performed. (C) Transcripts encoding
VP16-CREB were injected to one of two blastomeres (right panel) or to two of two
blastomeres (left panel). The expression of Nkx2.5was detected by in situ hybridization
(right panel) or by RT-PCR analysis on VMZ explants (n=18) (left panel). (D) Different
combinations of transcripts encoding activated MKK6 and CREB AMO were injected to
embryos and VMZ explants were isolated and grown to stage 14 (left panel). Different
combinations of transcripts encoding VP16-CREB and p38α AMO were injected to
embryos and DMZ explants were isolated and grown to stage 14 (right panel). Total
RNA was isolated and RT-PCR analysis was performed.
Fig. 4. FGF induces Nkx2.5 gene expression without affecting GATA4 gene expression. (A) Expression of FGF3 was detected on stage 13 embryos by whole-mount in situ hybridization
(n=20) (left). Stained embryos were transversely sectioned at the stained plane. One section is presented (right). Anterior transverse sections in stage 13 embryos followed by in
situ staining with a probe to Nkx2.5. Nkx2.5 is expressed in lateral mesoderm of anterior section (bottom left). Adjacent sections immunostained with antibodies to phospho-CREB
(S133). Red dots represent nuclear phospho-CREB staining. The embryo scheme indicates the plane section. (B) Transcripts encoding truncated FGF receptor (DN FGFR) were
injected to embryos and DMZ explants (n=36) were isolated and grown to stages 14 and 27. Total RNA was extracted and RT-PCR analysis was performed. (C) Transcripts encoding
DN FGFRwere injected to one cell embryos and the expression of GATA4 and Nkx2.5was analyzed by in situ hybridization of stage 16 embryos. (D) VMZ explants were dissected from
embryos injected with transcripts encoding DN FGFR or from control embryos. At stage 11, basic FGF (150 ng/ml) was added and explants were grown to stage 16. Total RNA was
extracted and RT-PCR analysis was performed.
379A. Keren-Politansky et al. / Developmental Biology 335 (2009) 374–384Nkx2.5 (right panel). Together these data support p38α and CREB
functioning in the same pathway in which p38α is upstream of CREB.
FGF signaling is involved in initiating Nkx2.5 expression
Next, we asked which of the secreted ligands involved in
cardiogenesis may affect the intracellular pathway initiating Nkx2.5
expression. Since FGF signaling was implicated in the initiation of
cardiac gene expression both is zebraﬁsh (Reifers et al., 2000) and inchick (Alsan and Schultheiss, 2002), we investigated its involvement
in initiating Xenopus Nkx2.5 expression. To establish possible
involvement of FGF, the expression of FGF3 was analyzed by whole-
mount in situ of stage 13 embryos (Fig. 4A, left panel). FGF3
expression appears as two symmetrical stripes at the anterior part
of the embryo. Transverse sections of the same embryos indicate that
the expression is speciﬁc to neural ectoderm of the future mid-hind
brain (Fig. 4A, right panel) (Tannahill et al., 1992). Ectoderm
expression of FGF3 was approximate to the expression zone of
380 A. Keren-Politansky et al. / Developmental Biology 335 (2009) 374–384Nkx2.5 that was detected mostly in the mesoderm and endoderm of
adjacent sections and to phosphorylated CREB in dorsal and lateral
mesoderm and endoderm (Fig. 4A, lower panel). Expression of FGF3
and possibly other FGF ligands (Lea et al., 2009) at the immediate
vicinity of Nkx2.5 expression may reﬂect functional relationships
between these molecules. To elucidate a possible role of FGF signaling
in the initiation of Nkx2.5 expression, FGF signaling activity was
inhibited by the expression of truncated receptor of FGF (XFD)
(Amaya et al., 1993). Since XFD affects early events of mesoderm
formation and gastrulation movements, it was injected at low levels
to allow development of embryos to neurulation. Expression of early
cardiac markers was analyzed by RT-PCR (Fig. 4B) and in situ
hybridization (Fig. 4C). The levels of Nkx2.5 were reduced while
those of GATA4were barely affected (Fig. 4B). The levels ofMyocardin
were reduced at early stage while induced at late-stage embryos.
Inhibition of Nkx2.5 expression was better detected at stage 16
embryos analyzed by in situ hybridization (Fig. 4C). The expression of
GATA4 was not affected. The role of FGF in Nkx2.5 expression was
further investigated; stage 11 VMZ explants were incubated with
basic FGF (FGF2) (150 ng/ml), and the expression of pre- cardiac
markers was analyze by RT-PCR (Fig. 4D). Basic FGF induced the
expression of Nkx2.5 and cardiac actin without affecting GATA4 gene
expression. Nkx2.5 was not induced by bFGF in explants expressing a
truncated FGF receptor. The activity of bFGF was conﬁrmed by its
ability to induce the phosphorylation of ERK MAPK (SupplementaryFig. 5. Anterior neural ectoderm is necessary to induce mesodermal Nkx2.5 expression. (A)
were isolated and grown to stage 15. Half of the explants were used to extract RNA for RT-PCR
Animal caps were removed at stages 8–9 from whole embryos. “Mildly affected” embryos w
RT-PCR analysis of their RNA (upper) or to in situ hybridization with probes to Nkx2.5, Myo
Ectoderm was removed from some of the DMZ explants and was recombined with VMZ ex
was extracted and RT-PCR analysis was performed. (D) Several embryos were injected wit
allowed to grow to stage 15 and in situ hybridization with probes to Nkx2.5 and MyoD waFig. 2). Therefore, introduction of FGF at the proper developmental
time (stage 11) induces Nkx2.5 expression in ventral mesoderm.
Anterior neural ectoderm induces Nkx2.5 expression in cardiac
progenitors
Next, the possible involvement of anterior neural ectoderm in the
induction of Nkx2.5 expression was investigated. Antagonism of BMP
transforms ectodermal AC explants into anterior neural ectoderm
(Lamb et al., 1993). Hence, transcripts encoding truncated BMP
receptor (tBR) were injected to embryos and AC explants were
isolated. Expression of anterior neural markers (Otx2, Krox20) was
induced in these explants (data not shown). Interestingly, BMP
antagonism induced the expression of FGF3 and FGF8, as expected for
an acquired non-autonomous activity of this tissue (Fig. 5A).
Moreover, expression of Nkx2.5 but not of GATA4 was induced in
these explants. This raised the possibility that an autocrine FGF signal
was established and induced the expression of Nkx2.5. For that reason,
the expression of several FGF receptors was analyzed. FGFR1 was
expressed in control AC explants while the expression of FGFR3 and
FGFR4a was signiﬁcantly induced in neuralized explants (Fig. 5A).
Co-injection of truncated FGF receptor (XFD) reduced expression of
Nkx2.5. Mesoderm markers were not identiﬁed in these explants
(not shown). Therefore, induction of anterior neural ectoderm in AC
explants generates FGF signaling and Nkx2.5 expression. In addition,Transcripts encoding truncated BMP receptor were injected and AC explants (n=36)
analysis (upper) and the other half to extract proteins forWestern analysis (lower). (B)
ere allowed to grow to stage 15, and whole embryos were extracted and subjected to
D, OTX2 and Krox20 (lower). (C) DMZ and VMZ explants were dissected at stage 10.25.
plants (pairs of VMZ: dorsal ectoderm) or grown alone (ecto.). At stage 15, total RNA
h mRNA encoding FGF8, and animal caps were removed at stages 8–9. Embryos were
s performed.
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injection of truncated FGF receptor reduced its level (Fig. 5A, lower).
The several bands detected with anti phospho-CREB antibody may
represent alternative splice products and/or close family members
like ATF1 (Mayr and Montminy, 2001). Next, we investigated the
effect of ectoderm ablation on Nkx2.5 expression in whole embryos.
Animal caps were surgically removed (stages 8–9), and embryos were
developed to stage 15 (Fig. 5B). Embryos lacking ectoderm failed to
express Nkx2.5, but not GATA4 (see RT-PCR and in situ hybridization
results). The expression of paraxial mesoderm marker MyoD was not
affected indicating that early mesoderm development was not
affected while the expression of anterior neural ectoderm markers
Krox20 and Otx2 was signiﬁcantly reduced conﬁrming that ectoderm
was considerably removed (in situ results). Therefore, ectoderm is
necessary for the early expression of cardiac Nkx2.5 but is not
required for early paraxial mesoderm gene expression (MyoD). Next,
we established a microsurgical technique to selectively remove
ectoderm from DMZ explants (stage 10). The removal of ectoderm
was validated by the reduced expression of anterior neural markers
(Otx2, Krox20) normally expressed in DMZ explants. The removed
ectoderm was conjugated to VMZ explants of the same embryos, and
explants were cultured to stage 15 (Fig. 5C). Removal of ectoderm
from DMZ explants reduced the expression of Nkx2.5 while induced
the expression of GATA4. The expression of other lateral mesodermFig. 6. Induction of Nkx2.5 by FGF is mediated by p38 MAPK and not by ERK MAPK. (A) DMZ
allowed to develop to stage 16. Half of the explants were used to extract RNA for RT-PCR an
DMZ explants were cultured and processed as above, except their incubation in U0126 (30 μ
SB203580 (30 μM). (D) Transcripts encoding FGF8 were injected and VMZ explants (n=36)
(30 μM). Half of the explants were used to extract RNA for RT-PCR analysis (left) and the rest
transcripts encoding FGF8 and CREB AMO were injected to embryos, and VMZ explants w
performed.genes, such as Myf5 and MyoD, was even induced in the absence of
ectoderm, excluding a possible accidental removal of mesoderm in
this procedure (Fig. 5C, right panel). On the other hand, the
expression of Nkx2.5 was induced while that of GATA4 was not
induced in recombinant VMZ/dorsal ectoderm explants. In a control
experiment, the expression of mesoderm markers, MyoD and Myf5,
was not detected in isolated ectoderm explants. These data suggest
that neural ectoderm is the inducer Nkx2.5 expression in mesodermal
explants. Next, we analyzed whether ectopic expression of FGF could
rescue Nkx2.5 expression in AC-deﬁcient embryos (Fig. 5D). As shown
in Fig. 5B, surgical removal of AC from embryos prevented Nkx2.5
expression. However, injection of mRNA encoding FGF8 to embryos
that later underwent the same microsurgical procedure induced
signiﬁcant expression of Nkx2.5 throughout the dorsal axis and
posterior region. Ectopic expression of FGF also expanded the lateral
staining of MyoD. Therefore, ectopic FGF expression induced dorsal
expression of Nkx2.5 in whole embryos missing ectodermal
structures.
FGF affects Nkx2.5 expression via p38 MAPK and not ERK MAPK
To investigate the relationship between FGF and p38 MAPK/CREB
signaling in the expression of Nkx2.5, DMZ explants were incubated
with pharmacological inhibitors of several signaling molecules (Fig. 6).explants (n=36) were dissected and at stage 11 were cultured in SU 5402 (30 μM) and
alysis (left) and the rest were used to extract proteins for Western analysis (right). (B)
M). (C) DMZ explants were cultured and processed as above, except their incubation in
were dissected and gown from stages 11 to 15 in the absence or presence of SB203580
were used to extract proteins forWestern analysis (right). (E) Different combinations of
ere dissected at stage 10+. RNA was extracted at stage 15 and RT-PCR analysis was
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kinase activity was added at stage 11 to DMZ explants (Mohammadi et
al., 1997). Incubation of DMZ explants with the inhibitor reduced the
expression of Nkx2.5 andMyocardin without affecting GATA4 (Fig. 6A).
This result links FGF signaling to the initiation of Nkx2.5 expression by
bypassing its earlier effects on mesoderm speciﬁcation. Expectedly, SU
5402 inhibited phosphorylation of ERK MAPK, a known intracellular
target of FGF (Fig. 6A). It also prevented the phosphorylation of CREB
(phospho-S133), indicating that CREB was phosphorylated in response
to FGF signaling. Similar results were observed with Alk4-expressing
AC explants (Supplementary Fig. 3). Addition of SU 5402 prevented
CREB phosphorylation and the induced expression of Nkx2.5 but not of
GATA4. The ERK MAPK pathway was considered before as the major
effector of FGF signaling in Xenopus development (reviewed in Tsang
and Dawid, 2004). To inhibit the ERK MAPK pathway, U0126 (MEK
inhibitor) was added to DMZ explants (Fig. 6B). Phosphorylation of ERK
was largely prevented in the presence of U0126, conﬁrming its activity.
Interestingly, the inhibitor failed to affect the phosphorylation of CREB,
relative to its phosphorylation in control DMZ explants. Therefore, ERK
MAPK is likely not the kinase phosphorylating CREB. Furthermore, the
expression of Nkx2.5 was not affected by U0126 (Fig. 6B). Thus, ERK
MAPK is not the intracellular pathway downstream of FGF affecting
Nkx2.5 expression. Since our previous studies (Keren et al., 2005,
2008) and results presented here (Fig. 3D) indicate that CREB is
affected by the p38 MAPK pathway, we incubated DMZ explants in the
presence of SB 203580, an inhibitor of p38α and β (Fig. 6C). Expression
of Nkx2.5 was abolished (left panel) and CREB phosphorylation was
prevented (right panel) in the presence of SB 203580. Together, these
results illuminate the roles of FGF and p38 MAPK signaling in the
initiation of Nkx2.5 expression while excluding a possible role of ERK
MAPK in the process. Since p38 knockdown may affect some anterior
structures other than the heart (see Fig. 1), we took advantage of the
explant assay to investigate if inhibition of FGF or p38 affected anterior
neural expression. Treatment of DMZ explants in SU 5402 or SB 203580
did not affect the expression of anterior markers such as Otx2 and
Krox20 and XAG1 suggesting that inhibition of Nkx2.5 by FGF or p38
inhibitors in this assay was independent of possible anterior neural
defects (Supplementary Fig. 4).
To further examine the relations of FGF and the intracellular p38/
CREB pathway, transcripts encoding FGF8 were injected to embryos
and the expression of cardiac markers was analyzed in VMZ explants
(Figs. 6D, E). The activity of injected FGF8 was conﬁrmed by the
induction of ERKMAPK phosphorylation (Supplementary Fig. 2). FGF8
induced the expression of Nkx2.5 in VMZ explants and reduced GATA4
expression in those explants. Additional treatment of explants with
p38 MAPK inhibitor (SB) at stage 10.25 reduced Nkx2.5 and induced
GATA4 expression, restoring their levels in control VMZ explants
(Fig. 6D). Similarly, co-injection of CREB morpholino with transcripts
encoding FGF8 prevented the expression of Nkx2.5 that was induced
by FGF8 alone (Fig. 6E). We conclude that p38 and CREB activities are
necessary for the induction of Nkx2.5 expression by FGF signaling.
Discussion
The anterior bilateral expression of Nkx2.5 in gastrulating embryos
is correlated with cardiac competence of these cells. Therefore,
knowledge of the signals initiating Nkx2.5 expression can shed light
at the earliest events specifying cardiac fate.
Intracellular signaling pathway initiating Nkx2.5 expression in cardiac
progenitors
Previous studies focused at the extracellular ligands involved in
cardiac expression. The participation of FGF and BMP signals in Nkx2.5
expression at different cardiac developmental stages was demon-
strated in deferent vertebrate model systems (Schultheiss et al., 1997;Barron et al., 2000; Reifers et al., 2000;Walters et al., 2001; Abu-Issa et
al., 2002; Alsan and Schultheiss, 2002). Still, the intracellular
mediators remain relatively unexplored. We demonstrate the in-
volvement of p38MAPK and the CREB transcription factor, sharing the
same pathway regulating the initial expression of Nkx2.5. The
involvement of this pathway in the expression of Nkx2.5 is
demonstrated by loss and gain of function experiments. Loss of
function was achieved by knocking down p38α (Keren et al., 2005)
and CREB (Keren et al., 2008) using antisense morpholino oligonu-
cleotides, the expression of inactive variant of MKK6 and a
pharmacological inhibitor of p38 MAPK. Gain of function was
achieved by expression of constitutive active variants of MKK6 (the
activating kinase of p38MAPK) and VP16-CREB. Using different whole
embryo and explant assays, we ﬁnd that modulation of these proteins
affect the expression of Nkx2.5 but not of GATA4. The ﬁnding that
GATA4 expression is not affected by these proteins emphasizes the
speciﬁcity of this pathway. GATA4 expression is initiated at blastula in
prospective mesoendoderm mostly at the dorsal side (Fletcher et al.,
2006), while Nkx2.5 expression is initiated at late gastrula (Tonissen
et al., 1994; Sparrow et al., 2000) and its expression is conﬁned to
anterior-lateral mesoderm. At this stage, GATA4 expression is at list
partially overlapping with that of Nkx2.5. Therefore, it might not be
surprising that different signaling pathways participate in the
initiation of Nkx2.5 and GATA4 gene expression. Since p38/CREB
function in mesoderm patterning (Keren et al., 2008), it was
important to elucidate its independent function in the initiation of
Nkx2.5 expression. The results presented here indicate a patterning-
independent function of this pathway in the induction of Nkx2.5
expression. First, the observation of overlapping expression of
phospho-CREB (active) and Nkx2.5 in embryos at initial stages of
Nkx2.5 expression. Second, knockdown of p38 or CREBwas performed
with limited morpholino concentrations that did not affect early
patterning in any signiﬁcant manner and may therefore allow detect
their effect on later developmental stages. Third, speciﬁc inhibition of
Nkx2.5 expression was observed in explants that were incubated with
a pharmacological inhibitor of p38 (SB 203580) at the proper
developmental stage (late gastrula). Regulation of Nkx2.5 expression
by CREB was suggested before (Sundaram et al., 2003). However, in
that study, it was suggested that maternal but not zygotic CREB
controlled initiation of Nkx2.5 expression. We would like to suggest
that the results in that study reﬂect earlier patterning defects than the
results presented in our study. Future studies will prove whether
CREB functions directly at the Nkx2.5 promoter as it may happen in
drosophila (Venkatesh et al., 2000).
FGF functions to initiate Nkx2.5 expression
Several signaling ligands were proposed to promote cardiac
development in vertebrates. The signals affecting Xenopus cardiac
development include antagonists of the canonical Wnt pathway
(Marvin et al., 2001; Schneider and Mercola, 2001; David et al., 2008)
and at the same time agonists of non-canonical Wnt pathway such as
Wnt11 (Pandur et al., 2002; Garriock et al., 2005; Afouda et al., 2008).
BMP signaling is required in Xenopus at several stages of cardiac
development like cell migration, differentiation and heart looping, but
is dispensable for the initial expression of cardiac regulators
(Breckenridge et al., 2001; Walters et al., 2001; Peterkin et al.,
2003). FGF signaling is required during the initiation of cardiac gene
expression in zebraﬁsh (Reifers et al., 2000) and chick (Lough et al.,
1996; Alsan and Schultheiss, 2002). A recent Xenopus study that
followed later-stage heart development (from stage 22 on) indicated
a role of FGF signaling in cardiomyocyte survival and proliferation
(Langdon et al., 2007). Interestingly, the role of FGF signaling in early
cardiac development was not considered in Xenopus. We show for the
ﬁrst time that FGF signaling is necessary for the initiation of Nkx2.5
expression. Expression of dominant-negative receptor of FGF prevents
383A. Keren-Politansky et al. / Developmental Biology 335 (2009) 374–384Nkx2.5 and heart formation in whole embryos. The incubation of stage
11 DMZ explants with a pharmacological inhibitor of FGF receptor (SU
5402) prevented Nkx2.5 expression, further illuminating that FGF
signaling is necessary at the proper developmental stage of Nkx2.5
initiation. Alternatively, incubation of stage 11 VMZ explants with
bFGF induced Nkx2.5 gene expression. These results dissociate the
direct effect of FGF on cardiac progenitors from a possible general
patterning of Spemann organizer's secreted ligands. BMP and Wnt
antagonists of the Spemann organizer are necessary for the induction
of cardiac progenitor cells, though their role in cardiac development
cannot be separated from their function in patterning. The distinct
expression of FGF3 in proximity and during the initiation of Nkx2.5
expression indicates of a more direct role of this pathway. Interest-
ingly, in Xenopus as in the chick (Alsan and Schultheiss, 2002), FGF
selectively affected the expression of Nkx2.5 and not the expression of
GATA4.
It should be emphasized that FGF ligands other than FGF3 may be
involved in Nkx2.5 expression. A recent study that systematically
investigated the expression of 17 FGF ligands in the developing Xe-
nopus tropicalis reveals a complex expression pattern (Lea et al.,
2009). For example, FGF8, like FGF3, is expressed at late gastrula at the
mid-hindbrain boundary and may function redundantly with FGF3.
Indeed, in our preliminary studies, morpholino-mediated knockdown
of FGF3 did not affect Nkx2.5 expression, indicating the involvement
of additional FGF ligands (A.K.P., unpublished results). Moreover, our
results indicate that different FGF ligands, bFGF (FGF2) and FGF8,
induce the expression of Nkx2.5. Therefore, we should consider the
involvement of more than one FGF ligand in the initiation of Nkx2.5
expression.
Anterior neural ectoderm is the source of FGF signal initiating
Nkx2.5 expression
The next question of interest is which tissue at the environment of
lateral mesoderm expressing Nkx2.5 secretes FGF ligands that could
initiate the intracellular signaling events. Analysis of the expression of
FGF3 by whole-mount in situ hybridization and in transverse section
of stage 13 embryos detected speciﬁc expression in anterior neural
ectoderm (neural plate). Mesoderm (paraxial and lateral) in this
region expresses FGF receptors (Monsoro-Burq et al., 2003), indicat-
ing that all elements necessary for signaling are expressed around the
time of Nkx2.5 initiation. Prior to the present work, two germ layers,
dorsal mesoderm (Spemann organizer) and the underlying endoderm
were considered as the only signaling tissues inducing cardiac
progenitors (Jacobson and Sater, 1988; Sater and Jacobson, 1990;
Nascone and Mercola, 1995; Schultheiss et al., 1995; Foley et al.,
2007). We would like to suggest anterior neural ectoderm as an
additional inducer of cardiac progenitors. We present several lines of
evidence supporting this assumption: (a) surgical removal of animal
caps resulted with no expression of Nkx2.5 and heartless embryos. (b)
Neuralized animal cap explants (expressing DN BMPR) express FGF
ligands, FGF receptors and Nkx2.5. Induction of Nkx2.5 expression is
mediated by autocrine FGF signaling since the co-expression of a
truncated FGF receptor inhibited Nkx2.5 gene expression. (c) Removal
of ectoderm cells from DMZ explants decreased the expression of
Nkx2.5. (d) Recombining an ectoderm tissue removed from DMZ
explants with VMZ explants induced the expression of Nkx2.5.
Therefore, at the earliest speciﬁcation stages, anterior ectoderm
provides the signal for Nkx2.5 expression. Interestingly, two reports
indicating the involvement of anterior ectoderm on Xenopus heart
development suggested a dorsal inhibitory signal that restricted heart
development only to the far ventral region (Rafﬁn et al., 2000;
Garriock and Drysdale, 2003). Rafﬁn and colleagues (2000) suggest
that an inhibitory signal emanating from the neural tube limits the
expression domain of Nkx2.5 and differentiation of the lateral heart
ﬁeld expressing Nkx2.5 while enabling differentiation of the farventral heart ﬁeld. Garriock and colleagues (2003) recombined whole
embryos (twins) at the end of gastrulation and showed that the
dorso-anterior surface of one embryo inhibited the expression of
Nkx2.5 and GATA4 at the ventral cardiac ﬁeld of a second embryo.
These inhibitory effects were detected in late neurulation at the
ventral heart ﬁeld and therefore may reﬂect a later function of the
dorsal neural ectoderm to limit heart development to the ventral end.
The positive effect of neural ectoderm that we describe is likely earlier
than those described in the other studies. At stage 12, when Nkx2.5
expression is initially detected as two anterior dorsal lateral patches, it
is located proximal to the anterior neural plate. It is more likely that at
this stage of Nkx2.5 initiation, the adjacent neural tissue plays an
inductive rather than a suppressive role. Whether neural ectodermal
induction of cardiac progenitors is unique to Xenopus or represents a
broader evolutionary event in vertebrates remained to be investigat-
ed. A similar expression pattern of FGF8 in the mid-hind brain
boundary at tailbud stage close to the expression domain of Nkx2.7
which includes cardiac precursors in zebraﬁshmay indicate of a more
general function of anterior neural ectoderm in the initiation of Nkx
expression (Lee et al., 1996; Reifers et al., 2000).
FGF-p38-CREB relations in cardiac development
The involvement of FGF signaling in developmental events such as
mesoderm induction and neural speciﬁcation are mediated by Ras-
ERK MAPK signaling (Gotoh et al., 1995; Uzgare et al., 1998). More
recently, studies of Amaya and colleagues indicated that regulators of
receptor tyrosine kinases from the Sprouty and Spred families
modulate different signaling pathways downstream of the FGF
receptor (FGFR) and consequently different developmental processes
(Sivak et al., 2005). In the present study, we suggest the involvement
of a new pathway, p38 MAPK/CREB, downstream of FGF in cardiac
speciﬁcation. Experiments presented here indicate that FGF activates
ERK and p38 MAPK pathways and possibly other intracellular events.
However, our results suggest that p38 MAPK is the mediator of FGF in
Nkx2.5 expression, while ERK is not involved in the process. Activation
of p38 MAPK by FGF signaling was reported in many cellular systems,
though the mechanism was not elucidated. A complex array of
signaling networks is emerging from many developmental studies. It
is obvious that crosstalk between signaling pathways could occur both
non-autonomously, by induction of secreted ligands affecting other
cells or intracellularly. For example, crosstalk between FGF, BMP and
Wnt was described in several developmental processes (Shimogori et
al., 2004; Hong et al., 2008). Thus, future studies will elucidate the
mechanism by which FGF induces p38 MAPK pathway.
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